NCT01568281View on ClinicalTrials.gov

Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
SafetyPharmacokinetics
Interventions
DRUG

Anastrozole ODF

Each volunteer will receive a single dose of Anastrozole ODF with water.

DRUG

Arimidex tablet

Each volunteer will receive a single dose of Arimidex tablet with water

DRUG

Anastrozole ODF

Each volunteer will receive a single dose of Anastrozole ODF without water.

DRUG

Arimidex tablet

Each volunteer will receive a single dose of Arimidex tablet with water

Trial Locations (1)

Unknown

Research Site, Fukuoka

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY